AMEEGO
Live / Applied — Third extension granted (statement of use) (as of 08 Sept 2026)
What this means for you
Not registered yet, but its 12 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98081253
- Mark type
- Stylized text
- Filed
- 12 Jul 2023
- Published for opposition
- 14 Jan 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, ophthalmic pharmaceuticals housed in a drug delivery system comprising a flexible cannula and syringe sold prefilled
- Class 010 — Medical apparatus: Drug delivery devices sold empty, namely, a flexible cannula for the delivery of pharmaceuticals to the subretinal space
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 09 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Sept 2026 — SOU EXTENSION 3 GRANTED
- 08 Sept 2026 — SOU EXTENSION 3 FILED
- 08 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2026 — SOU EXTENSION 2 GRANTED
- 03 Mar 2026 — SOU EXTENSION 2 FILED
- 03 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Sept 2025 — SOU EXTENSION 1 GRANTED
- 06 Sept 2025 — SOU EXTENSION 1 FILED
- 06 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jan 2025 — PUBLISHED FOR OPPOSITION